Health News and Scoops

CellTrak Technologies, Inc., a leading provider of integrated mobile solutions for the home healthcare, hospice, and private duty market segments in healthcare, today announced that the United States Patent and Trademark Office has issued Patent Number 8,019,622 to CellTrak. Titled “Home Health Point of Care and Administration System,” the 8,019,622 patent is directed to aspects of CellTrak’s mobile staff scheduling, tracking and travel management, electronic visit record and care plan administration, and communications systems.
Read more…

Recent statistics from the American Association of Oral and Maxillofacial Surgeons (AAOMS) reveal that by age 74, 26% of adults in America have lost all of their permanent teeth. The AAOMS study also states that 69% of adults between the ages of 35 and 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal, or tooth decay.
Read more…

MedHelp, the world’s largest health social network, announced the launch of Diet Diary – Calorie Counter in the Google Chrome Web Store. Diet Diary offers an enhanced experience to help users reach their weight goals with quick data entry, rapid page loading and a personalized interface. Additionally, the Diet Diary Chrome app syncs seamlessly with MedHelp’s personal health platform, including over 50 online and mobile health trackers, such as weight, water, food and exercise, and MedHelp’s popular My Diet Diary iPhone app. All three easily work together to allow people to manage their overall health anytime, anywhere. The app is available as a free install for the Chrome browser today at http://goo.gl/oyWMy.
Read more…

Hair loss is normally hereditary. But today, medical technology aims to provide hair loss solutions, something that has been around for some years now.

Scalpure, LLC a company based in Austin, TX, has introduced a hair loss product that is doing wonders for both male and female hair loss. Scalpure provides a new and very effective all natural approach to a problem that has long bewildered the World. Scalpure is exclusively available at http://www.Scalpure.com.

It is well-known that the cause of male and female pattern hair loss revolves around DHT (Dihydrotestosterone). Certain individuals, both men and women, are genetically predisposed to produce more DHT; however all of those individuals do not experience hair thinning, hair loss, and eventual baldness.

Through extensive research Scalpure learned that the individuals that keep their full heads of hair while producing more DHT display clean hair roots when examined under a high-powered microscope. The individuals with high DHT levels, average DHT levels or even low DHT levels that experience male or female pattern hair loss display an accumulation of DHT, sebum and debris on their hair roots. That build-up prevents the hair roots from receiving the necessary nutrients that normal blood flow is trying to deliver.

This shortens the growing stage (anagen) and/or lengthens the resting stage (telogen phase) of the follicle. This process causes hairs to get progressively finer and finer until they actually starve to death. DHT-induced hair loss is responsible for 95% of all male and female pattern hair loss.

(Source) PR Web

Mammography has long been the standard for detecting breast cancer in its early stages, however dense breast tissue can make tumors difficult to find. According to the New England Journal of Medicine, women with dense breast tissue are five times more likely to develop breast cancer.

Now a new type of ultrasound treatment, the Acuson S2000 Automated Breast Volume Scanner (ABVS), may help find what traditional mammography misses. In fact, a study published in 2008 found that adding a screening ultrasound examination to routine mammography revealed 28 percent more cancers than mammography alone. Recently FDA approved, ABVS is the world’s first multi-use automated breast volume ultrasound system.

This diagnostic tool provides a three dimensional view of the breast, allowing physicians to analyze the breast from front to back, top to bottom, and side to side; detecting even a small beginning of cancer. The system is also more comfortable for the patient because it’s non claustrophobic and radiation free.

Source